SC 13G Filing

Company

Benitec Biopharma Inc.

Filed

May 7, 2021

Accession Number

0000919574-21-003288

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →